Comparative Analysis of Matrix-Regenerating Agent and Corneal Cross-Linking in an Experimental Alkali Burn Rabbit Model

References

• Tuft SJ, Shortt AJ. Surgical rehabilitation following severe ocular burns. Eye (Lond). 2009 Oct;23(10):1966–71. doi:https://doi.org/10.1038/eye.2008.414.
   PubMed Web of Science ®Google Scholar
• Fish R, Davidson RS. Management of ocular thermal and chemical injuries, including amniotic membrane therapy. Curr Opin Ophthalmol. 2010 Jul;21(4):317–21. doi:https://doi.org/10.1097/ICU.0b013e32833a8da2.
   PubMed Web of Science ®Google Scholar
• Spoerl E, Huhle M, Seiler T. Induction of cross-links in corneal tissue. Exp Eye Res. 1998 Jan;66(1):97–103. doi:https://doi.org/10.1006/exer.1997.0410.
   PubMed Web of Science ®Google Scholar
• Spoerl E, Mrochen M, Sliney D, Trokel S, Seiler T. Safety of UVA-riboflavin cross-linking of the cornea. Cornea. 2007 May;26(4):385–89. doi:https://doi.org/10.1097/ICO.0b013e3180334f78.
   PubMed Web of Science ®Google Scholar
• Sharma N, Kaur M, Agarwal T, Sangwan VS, Vajpayee RB. Treatment of acute ocular chemical burns. Surv Ophthalmol. 2018 Mar-Apr;63(2):214–35. doi:https://doi.org/10.1016/j.survophthal.2017.09.005.
   PubMed Web of Science ®Google Scholar
• Karti O, Zengin MO, Cinar E, Tutuncu M, Karahan E, Celik A, Kucukerdonmez C. Effect of 1- and 6-Hour-Delayed Corneal Collagen Cross-Linking on Corneal Healing in a Rabbit Alkali-Burn Model: clinical and Histological Observations. Cornea. 2016 Dec;35(12):1644–49. doi:https://doi.org/10.1097/ICO.0000000000001050.
   PubMed Web of Science ®Google Scholar
• Barritault D, Gilbert-Sirieix M, Rice KL, Siñeriz F, Papy-Garcia D, Baudouin C, Desgranges P, Zakine G, Saffar JL, Van Neck J. RGTA® or ReGeneraTing Agents mimic heparan sulfate in regenerative medicine: from concept to curing patients. Glycoconj J. 2017 Jun;34(3):325–38. doi:https://doi.org/10.1007/s10719-016-9744-5.
   PubMed Web of Science ®Google Scholar
• Aifa A, Gueudry J, Portmann A, Delcampe A, Muraine M. Topical treatment with a new matrix therapy agent (RGTA) for the treatment of corneal neurotrophic ulcers. Invest Ophthalmol Vis Sci. 2012 Dec 13;53(13):8181–85. doi:https://doi.org/10.1167/iovs.12-10476.
   PubMed Web of Science ®Google Scholar
• Hughes L, Lockington D, Mantry S, Ramaesh K. Novel matrix ReGeneraTing Agent promotes rapid corneal wound healing. Clin Exp Ophthalmol. 2015 May-Jun;43(4):391–92. doi:https://doi.org/10.1111/ceo.12464.
   PubMed Web of Science ®Google Scholar
• Chappelet MA, Bernheim D, Chiquet C, Aptel F. Effect of a New Matrix Therapy Agent in Persistent Epithelial Defects After Bacterial Keratitis Treated With Topical Fortified Antibiotics. Cornea. 2017 Sep;36(9):1061–68. doi:https://doi.org/10.1097/ICO.0000000000001261.
   PubMed Web of Science ®Google Scholar
• Subasi S, Altintas O, Yardimoglu M, Yazir Y, Karaman S, Rencber SF, Kavram K. Comparison of collagen cross-linking and amniotic membrane transplantation in an experimental Alkali Burn Rabbit Model. Cornea. 2017 Sep;36(9):1106–15. doi:https://doi.org/10.1097/ICO.0000000000001276.
   PubMed Web of Science ®Google Scholar
• Roper-Hall MJ. Thermal and chemical burns. Trans Ophthalmol Soc U K. 1965;85:631–53.
   PubMedGoogle Scholar
• Saad HA, Terry MA, Shamie N, Chen ES, Friend DF, Holiman JD, Stoeger C. An easy and inexpensive method for quantitative analysis of endothelial damage by using vital dye staining and Adobe Photoshop software. Cornea. 2008 Aug;27(7):818–24. doi:https://doi.org/10.1097/ICO.0b013e3181705ca2.
   PubMed Web of Science ®Google Scholar
• Fini ME, Cook JR, Mohan R. Proteolytic mechanisms in corneal ulceration and repair. Arch Dermatol Res. 1998 Jul;290(Suppl):S12–23. doi:https://doi.org/10.1007/PL00007449.
   PubMed Web of Science ®Google Scholar
• Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol. 1997 Jan-Feb;41(4):275–313.
   PubMed Web of Science ®Google Scholar
• Arikan S, Karaca T, Ertekin YH, Comez AT, Ersan I, Demirtas S, Elmas S, Tufan HA, Turkon H. Effect of topically applied azithromycin on corneal epithelial and endothelial apoptosis in a rat model of corneal alkali burn. Cornea. 2016 Apr;35(4):543–49. doi:https://doi.org/10.1097/ICO.0000000000000730.
   PubMed Web of Science ®Google Scholar
• Dursun A, Arici MK, Dursun F, Ozec AV, Toker MI, Erdogan H, Topalkara A. Comparison of the effects of bevacizumab and ranibizumab injection on corneal angiogenesis in an alkali burn induced model. Int J Ophthalmol. 2012;5:448–51.
   PubMed Web of Science ®Google Scholar
• Mohan RR, Hutcheon AE, Choi R, Hong J, Lee J, Mohan RR, Jr AR, Zieske JD, Wilson SE. Apoptosis, necrosis, proliferation, and myofibroblast generation in the stroma following LASIK and PRK. Exp Eye Res. 2003 Jan;76(1):71–87. doi:https://doi.org/10.1016/S0014-4835(02)00251-8.
   PubMed Web of Science ®Google Scholar
• Kammergruber E, Rahn C, Nell B, Gabner S, Egerbacher M. Morphological and immunohistochemical characteristics of the equine corneal epithelium. Vet Ophthalmol. 2019 Nov;22(6):778–90. doi:https://doi.org/10.1111/vop.12651.
   PubMed Web of Science ®Google Scholar
• Gocmez SS, Yazir Y, Sahin D, Karadenizli S, Utkan T. The effect of a selective neuronal nitric oxide synthase inhibitor 3-bromo 7-nitroindazole on spatial learning and memory in rats. Pharmacol Biochem Behav. 2015 Apr;131:19–25. doi:https://doi.org/10.1016/j.pbb.2015.01.013.
   PubMed Web of Science ®Google Scholar
• Cejkova J, Olmiere C, Cejka C, Trosan P, Holan V. The healing of alkali-injured cornea is stimulated by a novel matrix regenerating agent (RGTA, CACICOL20): a biopolymer mimicking heparan sulfates reducing proteolytic, oxidative and nitrosative damage. Histol Histopathol. 2014 Apr;29(4):457–78.
   PubMed Web of Science ®Google Scholar
• Brignole-Baudouin F, Warnet JM, Barritault D, Baudouin C. RGTA-based matrix therapy in severe experimental corneal lesions: safety and efficacy studies. J Fr Ophtalmol. 2013 Nov;36(9):740–47. doi:https://doi.org/10.1016/j.jfo.2013.01.012.
   PubMed Web of Science ®Google Scholar
• Xu X, Liu T, Li H. Effect of collagen cross-linking on alkali burn-induced corneal neovascularization in rabbits. J Ophthalmol. 2018 Oct;9(2018):7325483.
   Google Scholar
• Colombo-Barboza M, Colombo-Barboza G, Felberg S, Dantas PE, Sato EH. Induction of corneal collagen cross-linking in experimental corneal alkali burns in rabbits. Arq Bras Oftalmol. 2014 Oct;77(5):310–14. doi:https://doi.org/10.5935/0004-2749.20140078.
   PubMed Web of Science ®Google Scholar
• Reim M, Bahrke C, Kuckelkorn R, Kuwert T. Investigation of enzyme activities in severe burns of the anterior eye segment. Graefes Arch Clin Exp Ophthalmol. 1993 May;231(5):308–12. doi:https://doi.org/10.1007/BF00919110.
   PubMed Web of Science ®Google Scholar
• Suschek CV, Schnorr O, Kolb-Bachofen V. The role of iNOS in chronic inflammatory processes in vivo: is it damage-promoting, protective, or active at all? Curr Mol Med. 2004 Nov;4(7):763–75. doi:https://doi.org/10.2174/1566524043359908.
   PubMed Web of Science ®Google Scholar
• Dighiero P, Behar-Cohen F, Courtois Y, Goureau O. Expression of inducible nitric oxide synthase in bovine corneal endothelial cells and keratocytes in vitro after lipopolysaccharide and cytokines stimulation. Invest Ophthalmol Vis Sci. 1997 Sep;38(10):2045–52.
   PubMed Web of Science ®Google Scholar
• Ehlers N, Hjortdal J, Nielsen K, Søndergaard A. Riboflavin-UVA treatment in the management of edema and nonhealing ulcers of the cornea. J Refract Surg. 2009 Sep;25(9):S803–806. doi:https://doi.org/10.3928/1081597X-20090813-08.
   PubMed Web of Science ®Google Scholar
• Barbier-Chassefière V, Garcia-Filipe S, Yue XL, Kerros ME, Petit E, Kern P, Saffar JL, Papy-Garcia D, Caruelle JP, Barritault D. Matrix therapy in regenerative medicine, a new approach to chronic wound healing. J Biomed Mater Res A. 2009 Sep 1;90(3):641–47. doi:https://doi.org/10.1002/jbm.a.32124.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li L, Reinach PS, Li Y, Ge C, Qu J, Chen W. Corneal collagen cross-linking with riboflavin and UVA regulates hemangiogenesis and lymphangiogenesis in rats. Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3702–12. doi:https://doi.org/10.1167/iovs.17-23036.
   PubMed Web of Science ®Google Scholar
• Berger T, Szentmáry N, Latta L, Seitz B, Stachon T. NF-κB, iNOS, IL-6, and collagen 1 and 5 expression in healthy and keratoconus corneal fibroblasts after 0.1% riboflavin UV-A illumination. Graefes Arch Clin Exp Ophthalmol. 2021 May;259(5):1225–34. doi:https://doi.org/10.1007/s00417-020-05058-z.
   PubMed Web of Science ®Google Scholar
• Clark AF. New discoveries on the roles of matrix metalloproteinases in ocular cell biology and pathology. Invest Ophthalmol Vis Sci. 1998 Dec;39(13):2514–16.
   PubMed Web of Science ®Google Scholar
• Zhang H, Li C, Baciu PC. Expression of integrins and MMPs during alkaline-burn-induced corneal angiogenesis. Invest Ophthalmol Vis Sci. 2002 Apr;43(4):955–62.
   PubMed Web of Science ®Google Scholar
• Yabluchanskiy A, Ma Y, Iyer RP, Hall ME, Lindsey ML. Matrix metalloproteinase-9: many shades of function in cardiovascular disease. Physiology (Bethesda). 2013 Nov;28(6):391–403.
   PubMed Web of Science ®Google Scholar
• Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci. 1998 Jan;39(1):18–22.
   PubMed Web of Science ®Google Scholar
• Price MO, Price FW Jr. Corneal cross-linking in the treatment of corneal ulcers. Curr Opin Ophthalmol. 2016 May;27(3):250–55. doi:https://doi.org/10.1097/ICU.0000000000000248.
   PubMed Web of Science ®Google Scholar
• Arvola RP, Robciuc A, Holopainen JM. Matrix regeneration therapy: a case series of corneal neurotrophic ulcers. Cornea. 2016 Apr;35(4):451–55. doi:https://doi.org/10.1097/ICO.0000000000000759.
   PubMed Web of Science ®Google Scholar
• Bata AM, Witkowska KJ, Wozniak PA, Fondi K, Schmidinger G, Pircher N, Szegedi S, Aranha Dos Santos V, Pantalon A, Werkmeister RM, et al. Effect of a matrix therapy agent on corneal epithelial healing after standard collagen cross-linking in patients with keratoconus: a randomized clinical trial. JAMA Ophthalmol. 2016 Oct 1;134(10):1169–76. doi:https://doi.org/10.1001/jamaophthalmol.2016.3019.
   PubMed Web of Science ®Google Scholar
• Jullienne R, Garcin T, Crouzet E, He Z, Renault D, Thuret G, Gain P. Evaluation of corneal epithelial wound healing after penetrating keratoplasty in patients receiving a new matrix therapy agent (regenerating agent). Eur J Ophthalmol. 2020 Jan;30(1):119–24. doi:https://doi.org/10.1177/1120672118808971.
   PubMed Web of Science ®Google Scholar
• Sharma A, Nottage JM, Mirchia K, Sharma R, Mohan K, Nirankari VS. Persistent corneal edema after collagen cross-linking for keratoconus. Am J Ophthalmol. 2012 Dec;154(6):922–926.e1. doi:https://doi.org/10.1016/j.ajo.2012.06.005.
   PubMed Web of Science ®Google Scholar
• Laborante A, Buzzonetti L, Longo C. Massive corneal edema treated with corneal cross-linking. Clin Ter. 2012;163:e1–4.
   PubMed Web of Science ®Google Scholar
• Kasai K, Kato N, Den S, Konomi K, Shinzawa M, Shimazaki J. A prospective, randomized clinical study comparing accelerated corneal collagen crosslinking with 5% NaCl hypertonic saline for bullous keratopathy in Asian eyes. Medicine (Baltimore). 2019 Dec;98(51):e18256. doi:https://doi.org/10.1097/MD.0000000000018256.
   PubMed Web of Science ®Google Scholar
• Khan MA. Distribution and measurement of corneal thickness in rabbits. Invest Ophthalmol Vis Sci. 2019 Jul 22;60(9):6805.
   Web of Science ®Google Scholar